High-Throughput, Multi-Parametric Analysis Accelerates Antibody Discovery Workflows

Therapeutic monoclonal antibodies are one of the fastest-growing classes of drugs, targeting many disease areas including cancer, autoimmune disorders, chronic inflammation and infectious disease.

Traditional antibody screening workflows can be labor-intensive, may not support high-throughput applications, don’t allow for direct antibody comparison and need large amounts of reagents.

Download this whitepaper to discover how high-throughput flow cytometry can provide quantitative data on:

• Binding
• Antibody internalization
• Antibody-dependent cell-mediated cytotoxicity, antibody-dependent cellular phagocytosis and T-cell activation